Graphite Bio, Inc. (NASDAQ:GRPH) Q1 2026 Earnings Call Transcript May 11, 2026
Operator: Good afternoon, ladies and gentlemen, and welcome to the LENZ Therapeutics’ First Quarter 2026 Financial Results Conference Call. [Operator Instructions] Following prepared remarks from management, we will conduct a question-and-answer session. And instructions will follow at that time. As a reminder, this call is being recorded. At this time I would like to turn the call over to Dan Chevallard, Chief...
